Flexible Spline Models for Blinded Sample Size Reestimation in Event‐Driven Clinical Trials
Pharmaceutical Statistics · 2025
DOI: 10.1002/pst.2459 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2025. Verfasst von Tim Mori und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Ger…. Hauptthemen laut MEDLINE: Models, Statistical, Research Design, Clinical Trials as Topic. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In event‐driven trials, the target power under a certain treatment effect is maintained as long as the required number of events is obtained. The misspecification of the survival function in the planning phase does not result in a loss of power. However, the trial might take longer than planned if the event rate is lower than assumed. Blinded sample size reestimation (BSSR) uses non‐comparative interim data to adjust the sample size if some planning assumptions are wrong. In the setting of an event‐driven trial, the sample size may be adjusted to maintain the chances to obtain the required number of events within the planned time frame. For the purpose of BSSR, the survival function is estimated based on the interim data and often needs to be extrapolated. The current practice is to fit standard parametric models, which may however not always be suitable. Here we propose a flexible spline‐based BSSR method. Specifically, we propose to carry out the extrapolation based on the Royston–Parmar spline model. To compare the proposed procedure with parametric approaches, we carried out a simulation study. Although parametric approaches might seriously over‐ or underestimate the expected number of events, the proposed flexible approach avoided such undesirable behavior. This is also observed in an application to a secondary progressive multiple sclerosis trial. Overall, if planning assumptions are wrong this more robust flexible BSSR method could help event‐driven designs to more accurately adjust recruitment numbers and to finish on time.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University, Düsseldorf, Germany.
- German Center for Diabetes Research (DZD), München-Neuherberg, Germany.
- Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
- Department of Biomedical Statistics, Graduate School of Medicine, Osaka University, Osaka, Japan.
- Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives (OTRI), Osaka University, Osaka, Japan.
- DZHK (German Center for Cardiovascular Research), Partner Site Lower Saxony, Göttingen, Germany.
ORCID-Profile: Tim Mori, Tim Friede
Zitieren
APA
Mori, T., Komukai, S., Hattori, S., & Friede, T. (2025). Flexible Spline Models for Blinded Sample Size Reestimation in Event‐Driven Clinical Trials. Pharmaceutical Statistics. https://doi.org/10.1002/pst.2459
Vancouver
Mori T, Komukai S, Hattori S, Friede T. Flexible Spline Models for Blinded Sample Size Reestimation in Event‐Driven Clinical Trials. Pharmaceutical Statistics. 2025. doi:10.1002/pst.2459
BibTeX
@article{Mori2025,
author = {Mori, Tim and Komukai, Sho and Hattori, Satoshi and Friede, Tim},
title = {Flexible Spline Models for Blinded Sample Size Reestimation in Event‐Driven Clinical Trials},
journal = {Pharmaceutical Statistics},
year = {2025},
doi = {10.1002/pst.2459}
}
EUVIMED